NCT06559332 - Coronary Artery Disease Assessment Strategies in TAVI Patients | Biotech Hunter

Enrollment

546

Participants

Timeline

Start Date

March 11, 2025

Primary Completion Date

March 31, 2030

Study Completion Date

March 31, 2032

Conditions

Transcatheter Aortic Valve ReplacementCoronary Artery DiseaseHeart Disease Risk Factors

Interventions

DIAGNOSTIC_TEST

Risk-based CAD management

Patients will not undergo routine coronary angiography prior to TAVI. Statin treatment of at least moderate intensity is recommended.

DIAGNOSTIC_TEST

Invasive coronary angiography

Routine invasive coronary angiography prior to TAVI. PCI recommended for coronary diameter stenosis of ≥ 80% (visual angiographic assessment) in coronary segments with a reference vessel diameter of at least 2.5 mm. Timing of PCI at the operators' discretion.

Trial Locations (1)

3010

RECRUITING

University Hospital Bern, Department of Cardiology, Bern